Sofiva Genomics Co.,Ltd. (TPEX:6615)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Healthcare Facilities & Services	385.71M	453.31M	466.80M	495.78M	508.42M
Healthcare Facilities & Services Growth	-14.91%	-2.89%	-5.84%	-2.49%	4.00%
Total	385.71M	453.31M	466.80M	495.78M	508.42M
Total Growth	-14.91%	-2.89%	-5.84%	-2.49%	4.00%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	368.68M	434.43M	452.32M	482.48M	496.37M
Taiwan Growth	-15.14%	-3.95%	-6.25%	-2.80%	4.38%
Other	17.03M	18.88M	14.48M	13.29M	12.05M
Other Growth	-9.81%	30.37%	8.94%	10.36%	-9.71%
Total	385.71M	453.31M	466.80M	495.78M	508.42M
Total Growth	-14.91%	-2.89%	-5.84%	-2.49%	4.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error